Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells

Laboratory Investigation

Volumn 79, Issue 2, 1999, Pages 243-251

  Weninger, Wolfgang ^c   Partanen, Taina A ^c   Breiteneder Geleff, Silvana ^c   Mayer, Christoph ^c   Kowalski, Heinrich ^c   Mildner, Michael ^c   Pammer, Johannes ^c   Stürzl, Michael ^a   Kerjaschki, Dontscho ^c   Alitalo, Kari ^c   Tschachler, Erwin ^b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b Universitatsklinik fur Dermatologie   (Austria)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

PODOPLANIN; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 3;

ARTICLE; CELL CULTURE; CELL TYPE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; KAPOSI SARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SARCOMA CELL;

BLOTTING, WESTERN; CELL LINE; ENDOTHELIUM; HUMANS; LYMPHATIC SYSTEM; MEMBRANE GLYCOPROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CELL SURFACE; RNA, MESSENGER; SARCOMA, KAPOSI; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 0033023309     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Achen MG, Jeltsch M, Kukk E, Makinen T, Vitali A, Wilks AF, Alitalo K, and Stacker-SA (1998). Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA 95:548-553.
2. Ackerman AB, Niven J, and Grant-Kels J (1982). Pyogenic granuloma vs. Kaposi's sarcoma, nodular stage. Differential diagnosis in dermatopathology. Philadelphia: Lea & Febiger, 150-153.
3. Albini A, Aluigi MG, Benelli R, Berti E, Biberfeld P, Blasig C, Calabro ML, Calvo F, Chieco-Bianchi L, Corbellino M, Del Mistro A, Ekman M, Favero A, Hofschneider PH, Kaaya E, Lebbe C, Morel P, Neipel F, Noonan DM, Parravicini C, Repetto L, Schalling M, Stürzl M, and Tschachler E (1996). Oncogenesis in HIV-infection: KSHV and Kaposi's sarcoma, Int J Oncol 9:5-8.
4. Beckstead JH, Wood GS, and Fletcher V (1985). Evidence for the origin of Kaposi's sarcoma from lymphatic endothelium. Am J Pathol 119:294-300.
5. Blasig C, Zietz C, Haar B, Neipel F, Esser S, Brockmeyer NH, Tschachler E, Colombini S, Ensoli B, and Sturzl M (1997). Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8. J Virol 71:7963-7968.
6. Boshoff C, Schulz TF, Kennedy MM, Graham AK, Fisher C, Thomas A, McGee JO, Weiss RA, and O'Leary JJ (1995). Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med 1:1274-1278.
7. Breiteneder-Geleff S, Matsui K, Soleiman A, Meraner P, Poczewski H, Kalt R, Schaffner G, and Kerjaschki D (1997). Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is downregulated in puromycin nephrosis. Am J Pathol 151:1141-1152.
8. Breiteneder-Geleff S, Soleiman A, Kowalski H, Horvat R, Amann G, Kriehuber E, Diem K, Weninger W, Tschachler E, Alitalo K, and Kerjaschki D (in press, 1999). Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: The use of podoplanin as specific marker for lymphatic endothelium. Am J Pathol.
9. Brown LF, Tognazzi K, Dvorak HF, and Harrist TJ (1996). Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma. Am J Pathol 148:1065-1074.
10. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, and Moore PS (1994). Identification of herpes-virus like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869.
11. Galland F, Karamysheva A, Pebusque M-J, Borg J-P, Rottapel R, Dubreuil P, Rosnet O, and Birnbaum D (1993). The flt4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor. Oncogene 8:1233-1240.
12. Ganem D (1997). KSHV and Kaposi's sarcoma: The end of the beginning? Cell 91:157-160.
13. Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, Swartz M, Fukumura D, Jain RK, and Alitalo K (1997). Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276:1423-1425.
14. Joukov K, Pajusola K, Kaipanen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo A (1996). A novel vascular endothelial growth factor, VEGF-C, is a ligand for the FLT4 (VEGFR-3) and KDR (VEGFR2) receptor tyrosine kinases. EMBO J 15:290-298.
15. Jussila L, Valtola R, Partanen TA, Salven P, Heikkilä P, Matikainen M-T, Renkonen R, Kaipainen A, Detmar M, Tschachler E, Alitalo R, and Alitalo K (1998). Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res 58:1599-1604.
16. Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VWM, Fang G-H, Dumont D, Breitman M, and Alitalo K (1995). Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92:3566-3570.
17. Lee J, Gray A, Yuan J, Luoh S-M, Avraham H, and Wood WI. vascular endothelial growth factor-related protein (1996). A ligand and specific activator of the tyrosine kinase receptor Flt4 Proc Natl Acad Sci USA 93:1988-1992.
18. Liu ZY, Ganju RK, Wang JF, Ona MA, Hatch WC, Zheng T, Avraham S, Gill P, and Groopman JE (1997). Cytokine signaling through the novel tyrosine kinase RAFTK in Kaposi's sarcoma cells. J Clin Invest 92:1798-1804.
19. Lunardi-Iskandar Y, Gill P, Lam VH, Zeman RA, Michaels F, Mann DL, Reitz MS Jr, Kaplan M, Berneman ZN, Carter D (1995). Isolation and characterization of an immortal neoplastic cell line (KS Y-1) from AIDS-associated Kaposi's sarcoma. J Natl Cancer Inst 87:974-981.
20. McNutt NS, Fletcher V, and Conant MA (1983). Early lesions of Kaposi's sarcoma in homosexual men. An ultrastructural comparison with other vascular proliferations in skin. Am J Pathol 111:62-77.
21. Nickoloff BJ and Griffiths CE (1989). The spindle-shaped cells in cutaneous Kaposi's sarcoma: Histologic simulators include factor XIIIa dermal dendrocytes. Am J Pathol 135: 793-800.
22. Pajusola K, Aprelikova O, Armstrong E, Morris S, and Alitalo K (1993). Two human FLT4 receptor tyrosine kinase isoforms with distinct carboxy terminal tails are produced by alternative processing of primary transcripts. Oncogene 8:2931-2937.
23. Pammer J, Plettenberg A, Weninger W, Diller B, Mildner M, Uthman A, Issing W, Stürzl M, and Tschachler E (1996). CD40 antigen is expressed by endothelial cells and tumor cells in Kaposi's sarcoma. Am J Pathol 148:1387-1396.
24. Rappersberger K, Tschachler E, Zonzits E, Gillitzer R, Hatzakis A, Kaloterakis A, Mann DL, Popow-Kraupp T, Biggar RJ, Berger R, Stratigos J, Wolff K, and Stingl G (1990). Endemic Kaposi's sarcoma in human immunodeficiency virus type 1-seronegative persons: Demonstration of retrovirus-like particles in cutaneous lesions. J Invest Dermatol 95:371-381.
25. Rappersberger K, Wolff K, and Stingl G (1993). Kaposi's sarcoma. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, editors: Dermatology in general medicine 4th ed. New York: MacGraw-Hill, Inc., 1244-1256.
26. Renne R, Blackbourn D, Whitby D, Levy J, and Ganem D (1998). Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells. J Virol 72:5182-5188.
27. Roth KW, Brandstetter H, and Stürzl M (1992). Cellular and molecular features of HIV-associated Kaposi's sarcoma. AIDS 6:895-913.
28. Schlingemann RO, Dingjan GM, Emeis JJ, Blok J, Warnaar SO, and Ruiter DJ (1985). Monoclonal antibody PAL-E specific for endothelium. Lab Invest 52:71-76.
29. Stürzl M, Brandstetter H, and Roth WK: Kaposi's sarcoma (1992). A review of gene expression and ultrastructure of KS spindle cells in vivo. AIDS Res Hum Retroviruses 8:1753-1763.
30. Tschachler E, Bergstresser PR, and Stingl G (1996). HIV-related skin diseases. Lancet 348:659-663.
31. Uccini S, Sirianni MC, Vinzenzi L, Topino S, Stoppacciaro A, La Parola IL, Capuano M, Masini C, Cerimele D, Cella M, Lanzaveccia A, Allavena P, Mantovani A, Baroni CD, and Ruco LP (1997). Kaposi's sarcoma cells express the macrophage-associated antigen mannose receptor and develop in peripheral blood cultures of Kaposi's sarcoma patients. Am J Pathol 150:929-938.
32. Weninger W, Uthman A, Pammer J, Pichler A, Ballaun C, Lang IM, Plettenberg A, Bankl HC, Stürzl M, and Tschachler E (1996). Vascular endothelial growth factor production in normal epidermis and in benign and malignant epithelial skin tumors. Lab Invest 75:647-657.
33. Weninger W, Rendl M, Pammer J, Mildner M, Tschugguel W, Schneeberger C, Stürzt M, and Tschachler E (1998). Nitric oxide synthases in Kaposi's sarcoma are expressed predominantly by vessels and tissue macrophages. Lab Invest 78: 949-955.